“3 Undervalued Healthcare Stocks Invstors Can Buy Right Now”
OSCR is undervalued; fair value >$41 vs price ~$30 implies >34% upside in 12-18 months driven by growth and cost control.
Last but not least, Oscar Health, one of the top healthcare companies in terms of integrating artificial intelligence into its operations to improve efficiency and performance.
It is one of the fastest growing healthcare companies since 2024. It has achieved a compound annual revenue growth rate of over 40%. Management anticipates compound annual revenue growth rates exceeding 20% from now until 2030.
It is controlling costs, and profits are improving as a result of this expansion in revenue and net profit.